BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16640173)

  • 21. The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
    Fossum E; Gleim GW; Kjeldsen SE; Kizer JR; Julius S; Devereux RB; Brady WE; Hille DA; Lyle PA; Dahlöf B
    J Intern Med; 2007 Oct; 262(4):439-48. PubMed ID: 17875180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P; de la Sierra A
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Success of blood pressure reduction in diabetic patients].
    Schernthaner G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of nifedipine in the treatment of hypertension.
    Pontremoli R; Leoncini G; Parodi A
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):43-50. PubMed ID: 15723574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 28. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
    Hanon O; Hoguin JC; Girerd X
    Arch Mal Coeur Vaiss; 2003; 96(7-8):744-7. PubMed ID: 12945215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension therapy: current and future strategies.
    Pardell H
    J Int Med Res; 1988; 16 Suppl 1():2A-7A. PubMed ID: 3065098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of hypertension in ischaemic heart disease.
    Hawkins NM; Dunn FG
    Curr Opin Cardiol; 2006 Jul; 21(4):273-8. PubMed ID: 16755194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers and coronary heart disease.
    Inzitari M; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond hypertension toward guidelines for cardiovascular risk reduction.
    Volpe M; Alderman MH; Furberg CD; Jackson R; Kostis JB; Laragh JH; Psaty BM; Ruilope LM
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1068-74. PubMed ID: 15533736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension management in patients with vascular disease.
    Kohlman-Trigoboff D
    J Vasc Nurs; 2004 Jun; 22(2):53-6. PubMed ID: 15179419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of hypertension in obesity.
    Narkiewicz K
    Obes Rev; 2006 May; 7(2):155-62. PubMed ID: 16629872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure lowering only or more? Has the jury reached its verdict?
    Julius S
    Am J Cardiol; 2007 Aug; 100(3A):32J-37J. PubMed ID: 17666196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.